Found 1498 matching trials
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer NA This clinical trial studies fludarabine phosphate, low-dose total body irra...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Show More Learn More & Join Trial
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia PHASE2 The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis PHASE1 This pilot clinical trial studies the side effects and best dose of ruxolit...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT EARLY_PHASE1 The purpose of this study is to evaluate the efficacy and safety of allogen...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Randomized Clinical Study Assessing Haplo vs. URD in AML NA This study compares haplo-identical family donor stem cell transplantation ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
Donor CHIP and Allogeneic HSCT Outcome N/A Current data on the impact of donor CHIP on long-term recipient outcome rem...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD PHASE1 Therapy of severe intestinal graft-versus-host disease (GVHD) despite the i...
Show More Location
Pavlov First Saint-Petersburg State Medical University
Learn More & Join Trial
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT PHASE1 The purposes of the study are to determine the maximum tolerated dose (MTD)...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial